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G-protein-coupled receptors (GPCRs) form the largest receptor family, relay environmental
stimuli to changes in cell behavior and represent prime drug targets. Many GPCRs are
classiﬁed as orphan receptors because of the limited knowledge on their ligands and coupling
to cellular signaling machineries. Here, we engineer a library of 63 chimeric receptors that
contain the signaling domains of human orphan and understudied GPCRs functionally linked
to the light-sensing domain of rhodopsin. Upon stimulation with visible light, we identify
activation of canonical cell signaling pathways, including cAMP-, Ca2+-, MAPK/ERK-, and
Rho-dependent pathways, downstream of the engineered receptors. For the human pseu-
dogene GPR33, we resurrect a signaling function that supports its hypothesized role as a
pathogen entry site. These results demonstrate that substituting unknown chemical activa-
tors with a light switch can reveal information about protein function and provide an optically
controlled protein library for exploring the physiology and therapeutic potential of under-
studied GPCRs.
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GPCRs sense diverse extracellular signals and are the targetsof ~one third of the available prescription drugs1–4. Uponactivation by ligands, GPCRs undergo conformational
changes and trigger intracellular signaling cascades that are G-
protein-dependent or -independent and involve secondary mes-
sengers, such as cAMP or Ca2+. In the human genome, ~350
genes encode non-olfactory GPCRs, and for ~200 of these
receptors, one or several natural ligands have been identiﬁed5,6.
In contrast, limited information is available on the ligands and
downstream signaling for the remaining putative GPCRs that are
commonly classiﬁed as orphan GPCRs7,8. Orphan receptors in
Class A, the largest GPCR class, exhibit wide tissue distribution,
with many expressed ubiquitously and some speciﬁcally in the
central nervous system, tissues involved in metabolism or the
immune system. Many orphan GPCRs are conserved across
species and have been implicated in a variety of dysfunctions,
including cancer, brain disorders and metabolic disorders9–12.
In light of their importance as regulators of physiology and as
potential drug targets, orphan GPCRs have been studied using
various approaches in the past decades. These include screening
of libraries to identify natural or man-made ligands and loss-of-
function or gain-of-function genetic experiments in vitro and
in vivo to reveal the receptor function and the physiological roles.
Because ligands and signaling functions could not be identiﬁed
for many orphan GPCRs, non-signaling modes of action, such as
modulation of the activity or the cellular localization of other
membrane proteins13–15, have been proposed. Consequently,
major remaining questions are whether orphan GPCRs couple to
canonical cellular signaling pathways, and what effects these
pathways elicit in speciﬁc tissues. Conceptually, the functions of
orphan receptors, for GPCRs and also other receptor families,
remain unknown as with current technologies it is not possible to
activate these proteins in real-time and in situ.
We hypothesized that functionalized orphan GPCRs, in which
activation by an unknown ligand is replaced with a known sti-
mulus through rational protein engineering, may enable experi-
mental studies that shed light on their function. We found
support for this idea of GPCR functionalization in work
describing novel GPCRs created using chimeric domain swapping
approaches that combine domains of two parent GPCRs16. The
underlying rationale is that functional elements of GPCRs, such
as the domains responsible for ligand sensing and those
responsible for cellular pathway activation, can be combined
modularly. Speciﬁcally, the brace of the N-terminus, three
extracellular loops and seven transmembrane domains are typi-
cally associated with the sensory domain responsible for ligand
binding and receptor activation, whereas the three intracellular
loops (ICL; ICL1, ICL2 and ICL3) and C-terminus are typically
associated with the signaling domain responsible for speciﬁc
downstream transmission (Fig. 1a)17–19. Thus, chimeric receptors
that link the sensory domain of a non-orphan GPCR with the
signaling domain of an orphan or understudied GPCR may be
capable of activating similar downstream pathways. We further
reasoned that the sensory domain of an opsin, i.e., a light-
activated GPCR, would be ideal for this purpose. Light is not only
an orthogonal and thus highly speciﬁc trigger in the context of
most cell types, but also provides activation with high spatial
precision (e.g., to address selected cells or tissues in an organism)
and temporal precision (e.g., to address selected time points
during development)20–23. Whereas examples of chimeric GPCRs
containing elements of vertebrate opsins and Class A or Class C
GPCRs exist24–29, light activation of GPCRs with unknown
function has never been demonstrated.
Here, we designed and engineered a library of chimeric
receptors that consist of the extracellular and transmembrane
elements of rhodopsin and the intracellular elements of 63 human
orphan and understudied GPCRs. When expressed hetero-
logously, we detected coupling to canonical cellular signaling
pathways including cAMP-, Ca2+-, MAPK/ERK-, and Rho-
dependent pathways for a subset of these receptors. This receptor
library complements the genome-wide experimental and com-
putational resources for GPCR interrogation30,31, enables novel
optogenetic experiments and provides diverse candidate proteins
for structure–function studies.
Results
Class A GPCR modularity and chimeric protein design. We
established a platform for the design and functional evaluation of
large numbers of light-activated chimeric receptors derived from
human orphan and understudied Class A GPCRs (Fig. 1b, c). Past
studies of chimeric GPCRs typically focused on receptors from
one or a few receptor families and applied diverse design meth-
odologies. Therefore, we ﬁrst systematically investigated if func-
tional modularity is broadly conserved among Class A GPCRs,
and whether primary sequences, which represent the information
available for all GPCRs, are sufﬁcient to design functional
chimeric receptors. To this end, we created and functionally
evaluated chimeric receptors of rhodopsin and nine prominent
reference GPCRs from ﬁve human Class A GPCR families
(Fig. 1c, top). In the sequence-based procedure, we computed a
multiple protein sequence alignment and identiﬁed the intracel-
lular elements of the nine reference GPCRs using those of rho-
dopsin as a guide17. We next engineered the chimeric genes using
a high-throughput genetic engineering method (described in
detail below) and expressed the proteins in cultured human
embryonic kidney 293 (HEK293) cells. The goal of this experi-
ment was to test if cell signaling responses induced by light sti-
mulation (blue and/or green light, maximal intensity ~400 μW
cm−2) of the chimeric receptors (Supplementary Data 1, 2) reca-
pitulate those of the corresponding reference GPCRs stimulated
by agonists (Supplementary Tables 1 and 2). To detect the acti-
vation of canonical GPCR signaling pathways, we primarily
applied the transcriptional reporters, in which ﬁreﬂy luciferase
(FF) is under the control of one of the three response elements
(Fig. 2a). The cAMP response element (CRE) is induced by
increased intracellular cAMP levels, such as those encountered
downstream of Gαs-coupled GPCRs32. In turn, CRE activity will
be reduced upon lowering of prestimulated cAMP levels by Gαi/o-
coupled receptor signaling. The serum response element (SRE)
contains binding sites for ternary complex factor (TCF) and
serum response factor (SRF), whereas the minimal SRE (SRE.L)
contains only the SRF binding site33–35. Both elements are
induced downstream of Gαq- and Gα12/13-coupled receptors,
either by MAPK pathway activation or RhoA activation33–35. We
choose transcriptional reporters for this platform because these
permitted large-scale screens of light-activated receptor libraries
(e.g., 63 receptors, see below) for several reasons. The ﬁrst reason
is that transcriptional assays register pathway activation in stable
reporter proteins, and thus allow for relatively long (four to 6 h)
experiments with continuous light stimulation. As a consequence
of long-term illumination, relatively low light intensities (<500
μWcm−2) are sufﬁcient for receptor activation. These intensities
can be applied to hundreds of samples in multiple 96-well plates
simultaneously using light-emitting diodes (LEDs) and are not
associated with unspeciﬁc photoeffects or phototoxicity. The
second and third reasons are that the activity of multiple signal
pathways can be detected using a universal luminescent readout,
and that a second constitutively expressed luciferase (Renilla
luciferase (RE)) can provide normalization for transfection efﬁ-
ciency and cell viability. Using these assays, we found all nine
light-activated chimeric receptors to act on the same pathways as
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their ligand-activated reference GPCRs (Fig. 2b, c). For instance,
stimulation of Gαs-coupled or Gαq-coupled adrenergic receptors
(β2AR or α1AR) with norepinephrine induced CRE and SRE/
SRE.L reporters and analogous responses were observed for light-
activated Opto-β2AR and -α1AR (Opto- indicates rhodopsin
chimeric receptors). Overall, we did not detect false positives
(emergence of new functions in chimeric receptors not observed
in reference GPCRs) or false negatives (loss of functions observed
in reference GPCRs). Furthermore, we found only one receptor, a
light-activated dopamine receptor 1 (termed Opto-D1R; Fig. 2c),
to exhibit activity in the absence of light. However, even in this
case, signaling was further increased by light stimulation. Col-
lectively, these results demonstrate that sequence information is
sufﬁcient to design the functional light-activated GPCRs for
members of several Class A GPCR families, and that these
receptors can be studied in a transcriptional reporter platform.
Reengineering 63 orphan and understudied GPCRs. Encour-
aged by these results, we developed a library of chimeric
receptors that contain the intracellular elements of 63 orphan and
understudied GPCRs (Fig. 1c, bottom, Supplementary Table 3,
Methods). We selected these proteins using a list of Class A
orphan GPCRs made available by the International Union
of Basic and Clinical Pharmacology (IUPHAR; see Methods)8. It is
noteworthy that this list contains orphan GPCRs as well as
understudied GPCRs, for which ligands have been identiﬁed
recently. Furthermore, we excluded from our study opsins and
proteins that were already assigned to Class A subfamilies with
according nomenclature. Preparing the 63 chimeric genes chal-
lenged existing genetic engineering strategies because a
total of nine alternating, variable-length segments of rhodopsin
and the 63 GPCRs (including a far C-terminal epitope of rho-
dopsin) had to be seamlessly linked (Fig. 1b). We developed a
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Fig. 1 Light-activated human orphan and understudied GPCRs. a In Class A GPCRs, extracellular and transmembrane domains are responsible for ligand
sensing, while intracellular domains couple with downstream signaling pathways. For orphan GPCRs, both the identity of ligands as well as of downstream
signals remain unknown. b In domain swapping experiments, the intracellular elements of orphan and understudied GPCRs were grafted onto the light-
activated GPCR rhodopsin, yielding light-activated, chimeric GPCRs. c Reference GPCRs and orphan and understudied GPCRs included in this study
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multiplexed variant of the Golden Gate protocol36 to achieve this
efﬁciently. In this method, a modiﬁed rhodopsin gene
and synthetic gene fragments, corresponding to the intracellular
elements of each GPCR, were digested by four bacterial
restriction enzymes and ligated by T4 viral ligase in one
reaction (Supplementary Figs. 1 and 2, Supplementary Tables 4
and 5). Because clones with correct insertions are selected as
the reaction progresses, this method offered high efﬁciency
(>90% clones with correct insertions) and was independent of
many reaction parameters (Supplementary Table 6; sequences
of the generated genes are given in Supplementary Data 1-4).
After genetic engineering, we ﬁrst investigated the expression of
the 63 proteins in the cultured human cells by staining
against a vesicular stomatitis virus glycoprotein (VSV-G)
epitope in their N-terminus. We observed intensities comparable
to that of rhodopsin for 61 receptors (two receptors,
Opto-GPR12 and -GPR15, showed lower, but detectable
signals) demonstrating efﬁcient chimeric receptor expression
(Supplementary Fig. 3).
Canonical signaling downstream of the engineered receptors.
We next performed a screen of the cellular signaling responses
elicited by chimeric receptors. In this screen, we assayed the 63
receptors with the transcriptional reporters in dark and light
conditions (blue and/or green light, maximal intensity ~400 μW
cm−2; each of the 504 receptor-pathway pairs was tested in at least
three independent experiments and each experiment consisted of
least duplicate wells). We observed speciﬁc signaling responses
upon light stimulation and generally no activity in the absence of
light (Fig. 3, Supplementary Table 7). The most potent induction
(threshold: 2.5-fold, see Data Analysis and Statistics) of the CRE
reporter was observed for six receptors (Opto-GPR1, -GPR21,
-GPR32, -GPR42, -GPR61, and -GPR135; range: 3.40 to 28.6-fold;
Fig. 3, green markers), of the SRE reporter for ﬁve receptors
(Opto-GPR3, -GPR18, -GPR68, -GPR78, and -GPR88; range: 2.70
to 8.20-fold; Fig. 3, orange markers) and of the SRE.L reporter for
one receptor (Opto-GPR78; 64.5-fold; Fig. 3, blue markers). We
also found potent reduction (threshold: 0.66-fold, see Data
Analysis and Statistics) of the CRE reporter for four receptors
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Fig. 2 Reporter assay and light-activated reference GPCRs. a Reporter vectors express ﬁreﬂy luciferase (FF) under the control of signaling-speciﬁc
enhancers and were co-transfected with Renilla luciferase (RE) to normalize for cell numbers/transfection efﬁciencies. Relative light units (RLU) were
detected for both luciferases separately. b Reporter activation by reference GPCRs stimulated by agonists (Supplementary Table 2; here, only receptors
that stimulated reporters are shown). c Reporter activation by the light-activated variants of reference GPCRs. In b and c, mean values ±s.e.m. (n= 6–8,
3–4 independent experiments) are shown. In tests for cAMP reduction, cAMP production was stimulated chemically before light treatment, as described in
Methods
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(Opto-GPR4, -GPR55, -GPR63, and -GPR150; range: 0.60 to 0.66-
fold; Fig. 3, red markers; cAMP production was stimulated before
light treatment, as described in Methods). We validated these
ﬁndings using secondary messenger assays. For the receptors that
induced the CRE reporter, we detected increased intracellular
cAMP concentrations using a real-time sensor (Supplementary
Fig. 4)37,38. For the receptors that induced the SRE/SRE.L reporter,
we detected increased intracellular Ca2+ concentration using
single-cell Ca2+ imaging (Supplementary Fig. 5). We did not
observe elevated basal cAMP or Ca2+ levels in the absence of light,
except for cells expressing Opto-GPR68. Furthermore, we con-
ﬁrmed membrane localization of those receptors that elicited these
signaling responses using confocal microscopy (Supplementary
Fig. 6). Collectively, these results demonstrate speciﬁc functions
associated with intracellular elements of orphan and understudied
GPCRs grafted onto rhodopsin in a functionalized receptor
library. For most of these receptors, no signaling functions were
reported previously, notable exceptions being proton- or
cannabinoid-sensing receptors (GPR4, GPR18, GPR18, GPR55
and GPR68)39–41.
Optical resurrection of GPR33. To demonstrate the further
potential of the functionalization approach, we focused on the
chemokine-like receptor protein GPR33. GPR33 stands out
among the listed receptors because its gene exhibits polymorphic
sequence variations including pseudogenization in hominoid
(including humans) and rodent species (Fig. 4a)42,43. The coin-
cident inactivation of GPR33 in several mammalian species
suggests selective pressure on the gene, potentially by a pathogen
that employed the protein as an entry site. Experimental support
for this hypothesis is missing because the signaling function and
internalization behavior of human GPR33 is currently not
understood. We addressed this question by resurrecting the
ancestral (i.e., not null pseudogene) human GPR33 allele in a
light-activated protein variant (Opto-GPR33; Fig. 4a, Supple-
mentary Data 3 and 4). We found that light stimulation of Opto-
GPR33 reduced CRE reporter activity and induced the SRE/SRE.L
reporters (Fig. 4b). This result suggests that the ancestral human
GPR33 receptor was capable of activating canonical signaling
pathways, including those commonly linked to chemoattractant
receptors that are related to GPR33. We furthermore found that
light activation of Opto-GPR33 triggered internalization and that
the C-terminus was required for this process (Supplementary
Figs. 7 and 8). Internalization upon activation may corroborate
the hypothesized role of GPR33 as a pathogen interacting and
entry factor, and collectively these results illustrate how optical
functionalization can be applied to resurrect an ancestral protein
function.
Discussion
GPCRs critically orchestrate multicellular physiology and are
implicated in a plethora of dysfunctions. Despite extensive efforts,
ligands for many putative GPCRs, which are classiﬁed as orphan
receptors, have remained unknown. Understanding the molecular
function of orphan GPCRs is essential to gauge their contribu-
tions to physiological processes and their potential as drug tar-
gets, but this has been hampered by the absence of methods that
permit their real-time and in situ activation. In addition, signaling
properties of GPCRs, such as preferential coupling to one or
several G-protein-dependent pathways, can currently not be
predicted based on sequence information due to com-
plex divergent receptor evolution30. To overcome these limita-
tions, we generated a functionalized receptor library, in which we
grafted the secondary structure elements associated with down-
stream signaling and trafﬁcking of 63 human Class A GPCRs
onto rhodopsin. The receptors we studied were orphan as well as
understudied receptors and recently, deorphanized receptors.
Functionalization was achieved using an efﬁcient genetic
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Fig. 3 Optical functionalization of 63 human GPCRs. Reporter activation by chimeric receptors stimulated with light. Squares are ﬁlled with false color
representations of mean FF RLU/RE RLU norm. values (n= 6–8, 3–4 independent experiments), as indicated by the scale bars. Also see Supplementary
Table 7 for tabulated results
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engineering method that allowed the seamless assembly of mul-
tiple gene fragments into complex fusion genes, and that might be
applicable also to engineering in other protein families. Our
general chimeric receptor approach was inspired by previous
studies that employed domain swapping to create GPCRs with
desired properties and to study GPCR structure–function rela-
tionships16–19. However, previous work on chimeric Class A
GPCRs typically recruited receptors from one family that are
likely structurally compatible as they respond to the same or
chemically related ligands and in many cases originate from a
common ancestor30,44. Furthermore, chimeric receptors that did
not show the predicted functionality have also been reported in a
small number of cases45,46. For our study, it therefore remained
to be systematically tested if functional modularity is maintained
between multiple Class A GPCR families. To address this point,
we compared signaling response elicited by nine reference GPCRs
activated by agonists to those of the corresponding chimeric
receptors activated by light. We found that optical functionali-
zation recapitulated the coupling speciﬁcity in these cases. It was
recently suggested that conformational changes during activation
of diverse Class A GPCRs converge on conserved contacts on the
intracellular side of the receptors (in particular, a conformational
switch encompassing residues 3×46, 6×37, and 7×5347). As a
consequence of this convergence, intracellular interfaces for
interaction with downstream partners are likely positioned
similarly in chimeric GPCRs and parent GPCRs, providing an
explanation for the success of the chimeric protein engineering
approach.
We observed potent coupling to downstream pathways for a
subset of the studied receptors. The canonical signaling
capabilities identiﬁed in our experiments and in future uses of
this library may guide drug discovery by identifying drug targets
and validating cellular screening assays. Our experiments were
focused on G-protein dependent signaling pathways, and it is
possible that the chimeric and parent receptors are capable of
activating pathways other than those tested here. In particular,
receptors may function only in speciﬁc cell types, e.g., because of
differentially expressed intracellular signaling proteins. The pre-
sented receptor library provides a technological basis for unco-
vering further signaling functions, as the palette of functional
assays and cell models is extended.
Highly conserved sequence motifs such as a three residue
stretch in transmembrane helix 3 (E/DRY; residues 3×49, 3×50,
and 3×51) or the above mentioned contacts near the intracellular
receptor surface are critically implicated in conformational
changes associated with GPCR activation. Receptors with non-
conservative substitutions in these motifs are known to have
altered or diminished signaling function47–49. We noticed an
accumulation of non-conservative and rare substitutions in these
motifs in some receptors included in our study, such as in
fourteen receptors with at least one non-conservative or unique
substitution in both the DRY motif and the three conserved class
A contact residues (Supplementary Table 8). These substitutions
raise the possibility that these receptors may exhibit non-
canonical activation modes and signaling function, and our
experimental results corroborate this idea as we did not observe
canonical pathway activation for the corresponding chimeric
receptors.
The receptor library complements other multireceptor and
genome-wide strategies for the interrogation of GPCRs30,31.
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Speciﬁcally, light-activated chimeric receptors may enable
exquisite control of signaling during development and in a variety
of physiological contexts because light can be delivered with
spatiotemporal precision in vitro and in vivo. In a complementary
strategy, chemically activated chimeric receptors may
allow for systemic and sustained regulation of signaling50. It is
important to note that the strength of pathway activation, which
is known to be biased by GPCR ligands, is likely not preserved in
engineered chimeric receptors. One additional use of the chimeric
receptor library may be to provide templates for structure eluci-
dation building on the past uses of the exceptionally stable rho-
dopsin core. Finally, the general approach of substituting
activation by unknown ligands or binding partners for activation
by light may be extended to other protein families because
functional modularity and domain swapping are not limited to
GPCRs51,52.
Methods
Availability of vectors and genes. All vectors and genes created in this study are
available through Addgene.org and from the authors.
Reference GPCR expression vectors. Reference GPCRs (Fig. 1c, top, Supple-
mentary Table 1) were obtained in mammalian expression vectors, except for D1R,
D2R, M1R and M2R that were subcloned into pcDNA3.1(−) using polymerase
chain reaction (PCR) and NotI, KpnI and HindIII restriction enzymes (oligonu-
cleotide primers 1 to 8, Supplementary Table 9). All genes were veriﬁed by DNA
sequencing and tested by agonist activation in the same experiments as the chi-
meric receptors.
Gene selection and curation. In April 2011, we retrieved the complete list of 94
expressed Class A GPCRs that were initially classiﬁed as orphans from the online
database of IUPHAR (http://www.guidetopharmacology.org/GRAC/
FamilyDisplayForward?familyId=16). Twenty-nine genes that were either opsins
or assigned to GPCR families with corresponding names were not considered for
experiments in this study but included in sequence alignments. Protein and mRNA
sequences were collected and curated manually where necessary: GPR79 was
excluded because its mRNA sequence could not be obtained, and for three proteins
the corresponding mRNA sequences were adjusted at single sites to match the
deposited protein sequences. Also, the recognition sequences of restriction enzymes
used in the cloning steps were removed from the nucleotide sequences using
macros written in Igor Pro (WaveMetrics).
Design of chimeric GPCR sequences. A multiple sequence alignment generated
using Muscle53, and a series of macros written in Igor Pro were used to design the
chimeric receptors. First, protein and nucleotide sequences (including those of
rhodopsin) were imported into Igor Pro and assigned unique identiﬁers.
Using macros, protein sequences were then randomized in their order, exported,
aligned with Muscle and reimported into Igor Pro. The intracellular elements
(four for each receptor: ICL1 to ICL3 and C-terminus) were then identiﬁed in the
protein alignment using the corresponding elements of rhodopsin17 as a guide. The
corresponding nucleotide sequences were retrieved and modiﬁed with
overhangs for genetic engineering. Complete C-termini were included. For further
validation, the intracellular elements determined using the above methodology
were compared to those predicted by membrane helix analysis. Except
for one receptor (GPR101), only minor differences between these two methods
were found. The chimeric GPR101 sequence is unlikely to result in a functional
protein.
Engineering of chimeric GPCR genes. We devised a multisite cloning
technique, based on TypeIIS restriction enzymes and Golden Gate cloning36, for
generation of the chimeric receptors (Supplementary Fig. 1). Our technique
differs from the original Golden Gate protocol, in that we used four enzymes with
distinct recognition sequences and one additional digestion step. We ﬁrst
prepared a mammalian expression vector (Supplementary Fig. 2, Supplementary
Table 5). This was necessary because common mammalian expression vectors are
not suited for cloning with TypeIIS restriction enzymes due to recognition
sites in the vector backbones. In our vector, based on the commercial vector
pcDNA3.1(−) (LifeTechnologies), six recognition sites for three TypeIIS restriction
enzymes (two for BsaI, one for BpiI/BbsI and three for LguI/SapI) were removed
using site-directed mutagenesis (Supplementary Fig. 2, Supplementary Table 5,
oligonucleotide primers 9 to 20, Supplementary Table 9). Next, a receiver
gene was designed and synthesized that contains (i) the extracellular and trans-
membrane elements of bovine rhodopsin, (ii) sequences for membrane integration
and antibody staining, and (iii) TypeIIS recognition sites in opposing orientation
(Supplementary Fig. 1, Supplementary Table 4). This gene was inserted
into the new vector using XhoI and EcoRI restriction enzymes. Synthetic gene
fragments corresponding to the intracellular elements of reference or orphan and
understudied GPCRs (determined as described above) were obtained as oligonu-
cleotides (Integrated DNA Technologies) or synthetic genes (GeneWiz) and
inserted into the receiver at a single or two sites in parallel. Reaction mixtures
(typical ﬁnal volume 20 μl) contained vector (100 ng), gene fragments corre-
sponding to the intracellular elements (one or two, not necessarily adjacent;
7.8 ng each), T4 ligase (1 μl), T4 ligase buffer and 5 units of the TypeIIS restriction
enzyme required to insert one of the two elements. This mixture was then cycled 11
times between 37 °C (for 2 min) and 16 °C (for 3 min). Next, ﬁve units of the
TypeIIS restriction enzyme required to insert the other element was added, fol-
lowed by further cycling (22 cycles). The enzymes were then heat-inactivated (50 °
C for 5 min, 80 °C for 10 min) and the vectors were digested with ﬁve units of an
additional restriction enzyme to remove unmodiﬁed receiver genes (AgeI, BlpI,
EcoRV or NotI; Supplementary Table 4). The reaction was then transformed into
competent E. coli cells, and one to two clonal DNA preparations were obtained
(two clonal DNA preparations were sufﬁcient because the success rate
of single fragment insertions was ~90%). The procedure was insensitive to the
number of cycles in the range from 33 to 60, but improved by the additional
digestion step (Supplementary Table 6). All genes were veriﬁed by DNA sequen-
cing. A small number of genes that could not be obtained using the cloning
technique right away were prepared using gene synthesis (EpochLifeScience). Note
that for future transfer or subcloning of the generated genes using PCR, universal
subcloning oligonucleotides using AclI, AgeI, AsISI, BlpI, EcoRV, NotI, PacI, PmeI,
and SalI are suited, as recognition sites for these enzymes are not found in any of
the genes.
Opto-GPR33 and its variants. Opto-GPR33 was designed and constructed, as
described above. The ﬂuorescent protein mCherry54 was a kind gift of R.Y. Tsien
(University of California San Diego). To obtain Opto-GPR33-mCherry, an AscI
restriction site was introduced before the stop codon of Opto-GPR33 using an
inverse PCR (oligonucleotide primers 21 and 22, Supplementary Table 9). In this
reaction, ampliﬁcation produced linear double-stranded DNA products with
terminal AscI restriction sites. Products were digested with AscI, ligated, and
propagated in E. coli cells. mCherry was then inserted after PCR using the AscI
restriction enzyme (oligonucleotide primers 23 and 24, Supplementary Table 9). To
obtain Opto-GPR33-BT, the biotinylation tag (BT; GLNDIFEAQKIEWHE) was
introduced at the protein N-terminus after the epitope with a ﬂexible linker using
an inverse PCR and phosphorylated oligonucleotides with split BT overhangs
(oligonucleotide primers 25 and 26, Supplementary Table 9). Opto-GPR33-
mCherry and Opto-GPR33-BT lacking the GPR33 C-terminus (Opto-GPR33-
mCherry-ΔCt and Opto-GPR33-BT-ΔCt) were obtained by inverse PCR using
oligonucleotides that bind to the retained sequences and contain ClaI restriction
sites (oligonucleotide primers 27 and 28, Supplementary Table 9). All genes were
veriﬁed by DNA sequencing.
Cell culture and transfection. HEK293 cells (American Type Culture Collection;
further authenticated by assessing cell morphology and growth rate) were
cultured in a mycoplasma-free environment in DMEM supplemented with 10%
FBS, 100 Uml−1 penicillin and 0.1 mgml−1 streptomycin in a humidiﬁed incu-
bator (37 °C, 5% CO2). Cells were lifted with trypsin (LifeTechnologies) and
transfected in DMEM supplemented with 5% FBS, either using Lipofectamine 2000
(LifeTechnologies) or a homemade reagent (1 mgml−1 polyethylenimine
in H2O; Polysciences). For transfection, vectors in Opti-MEM I (see below for
volumes and amounts) and transfection reagents in an equal volume of Opti-
MEM I were combined, incubated at room temperature for 5 min, and added
to the cells. Medium was replaced with complete or starve medium (see below)
after 6 h.
Transcriptional reporter assays. FF reporter vectors were obtained from Pro-
mega (CRE reporter: pGL4.29, SRE reporter: pGL4.33)35 or a kind gift of
D. Wu (Yale School of Medicine, SRE.L reporter)34. We chose transcriptional
reporters because they cover pathways with direct relevance for gene
regulation by GPCRs35 and are suited for experiments with light-activated recep-
tors (Main Text). The RE vector was obtained by subcloning the RE gene from
phRG-TK into pcDNA3.1(−) using PCR and NheI and XbaI restriction
enzymes (oligonucleotide primers 29 and 30, Supplementary Table 9). In
pcDNA3.1(−), RE is under constitutive control of the CMV promoter. 50,000 cells/
well were seeded in poly-L-ornithine (PLO)-treated (Sigma) 96-well plates
(white or black walls, clear bottoms; Greiner Bio-One). 6 h after transfection with
75 ng receptor vector, 75 ng FF vector and 7.5 ng RE vector in 25 μl Opti-
MEM I, the medium was changed to starve medium (DMEM supplemented with
0.5% FBS and antibiotics). 24 h after transfection, the cells were incubated
with 10 μM 9-cis retinal overnight. On the next day, the medium was changed to
CO2-independent medium (LifeTechnologies) supplemented with 0.5% FBS and
antibiotics, and the cells were stimulated with agonists (Supplementary
Table 2) or light for 6 h. Light stimulation was performed in an incubator (PT2499,
ExoTerra) modiﬁed with 450 LEDs (300 IP65, SMD3528, 150 IP66, SMD5050, 470
and 530 nm peak wavelength). Cells were stimulated at 37 °C with blue
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and green light (~400 μWcm−2), blue light only (~280 μWcm−2, for SRE repor-
ter), or shielded from light (wrapped in aluminum foil in the incubator). When
testing for a reduction of CRE reporter signals, cells were stimulated with 500 nM
5′-(N-ethylcarboxamido)adenosine 3 (NECA) for 5 min before the agonist or light
stimulation. Luminescence was developed using a dual luciferase assay (Dual-Glo,
Promega) following the manufacturer’s instructions for cell lysis, substrate addition
and quenching. RLU were determined in a microplate reader (Synergy H1M,
BioTek; gain 135, 1 s integration time).
cAMP mobilization. A genetically encoded real-time cAMP sensor (GloSensor-
22F37) was obtained as a synthetic gene in pcDNA3.1(−). A total of 10,000 cells/
well were seeded in 96-well plates and transfected with 100 ng receptor vector and
100 ng sensor vector. 6 h after transfection, the medium was changed to assay
medium (Leibovitz’s L15 medium supplemented with 10% FBS and antibiotics). 24
h after transfection the cells were incubated with 10 µM 9-cis retinal overnight. On
the next day, cells were incubated with 2 mM beetle luciferin (Promega) that was
reconstituted in 10 mM HEPES. Cells were equilibrated in the dark for 15 min at
37 °C, followed by recording RLU before (for 30 min) and after (for 15 min) light
stimulation. Light stimulation was performed using a custom, external array of
high-intensity LEDs (HLMP-CE35, Broadcom; ~9.6 mW cm−2, 505 nm peak
wavelength) for 2 to 10 s. Recordings were analyzed using initial ten data points
(for baseline) and the maximum value after stimulation (for percentage change;
Supplementary Fig. 4).
Ca2+ mobilization. A total of 50,000 cells/well were seeded on poly-L-lysine
(PLL)-treated 12 mm glass coverslips and transfected with 500 ng receptor
vector and 50 ng of a mammalian expression vector harboring the red ﬂuor-
escent protein mKate255(a kind gift of D.M. Chudakov, Shemiakin-Ovchinnikov
Institute of Bioorganic Chemistry/Evrogen). 6 h after transfection, the medium
was changed to complete medium. 24 h after transfection, cells were incubated
with 10 µM 9-cis-retinal overnight. For imaging on the next day, the coverslips
were washed in measurement buffer (5.4 mM KCl, 135 mM NaCl, 1.8 mM CaCl2,
0.9 mM MgCl2, 10 mM HEPES, 10 mM glucose, pH 7.6) and incubated with 5
µM Fura2-AM (Anaspec) for 25 min in the dark. Coverslips were transferred to
fresh buffer to allow dye maturation and were imaged on a customized inverted
microscope (Olympus IX50; ×20 magniﬁcation) equipped with a high-intensity
light source (DG-4, Sutter Instruments) and EMCCD camera (Luca, Andor).
Using MicroManager56, excitation wavelengths were alternated between 340,
380 and 470 nm for dye imaging and photoactivation (3 s frame rate, 400
frames). Individual cells were identiﬁed in the mKate2 images recorded prior to
Ca2+ measurements. Using pattern recognition macros written in Igor Pro,
Fura2 ﬂuorescence signals for individual cells were analyzed as time courses
(baseline: average of initial ten data points, response: maximum value; Supple-
mentary Fig. 5).
Opto-GPR33 internalization using mCherry. A total of 80,000 cells were seeded
on PLL-treated glass imaging dishes (MatTek Corporation) and transfected with
500 ng receptor vector (either Opto-GPR33-mCherry or Opto-GPR33-mCherry-
ΔCt). Images were acquired 24 h after transfection on a digital ﬂuorescence
microscope (EVOS-FL, ThermoFisher Scientiﬁc, ×20 magniﬁcation, excitation and
emission wavelengths were 531 ± 40 and 593 ± 40 nm, respectively). Cells were
classiﬁed (Type A: cells with internalized receptors, Type B: cells without inter-
nalized receptors) and counted manually but blinded to the experimental condi-
tion. Dishes were stimulated with blue light (~180 μWcm−2) in the incubator
described above for 30 to 60 min and analyzed before and after light stimulation.
Ratios of Type A cell counts and Type B cell counts deﬁne the internalization ratios
that are given in Supplementary Fig. 8a.
Opto-GPR33 internalization using biotinylation and labeling. A total
of 30,000 cells/well were transfected in 96-well plates with 100 ng BirAER vector that
encodes an ER-resident biotin ligase (a kind gift of A. Ting, Stanford University)
and 100 ng Opto-GPR33-BT, Opto-GPR33-BT-ΔCt or a transmembrane-
bound extracellular BT (TMD-BT; a kind gift of O. Thoumine, University of
Bordeaux57). 6 h after transfection, the medium was replaced and supplemented
with 10 µM biotin (Sigma-Aldrich). After 48 h, cells were incubated with 10 µM 9-
cis-retinal overnight. On the next day, the cells were washed with DPBS and
labeled with 10 µgml−1 HyLiteFluor555 (AnaSpec/Kaneka Eurogentec SA)
for 10min at 37 °C. After washing, the cells were placed in the incubator described
above either in blue light (~180 µW cm−1) or protected from light for 1 h. Cells
were ﬁxed with 4% PFA for 10min and ten images per well were acquired
on the digital ﬂuorescence microscope. Cells were classiﬁed (Type A: cells with
complete receptor internalization, Type B: cells with complete or partial membrane
localization) and counted manually, but blinded to the experimental condition.
Ratios of Type A cell counts and Type B cell counts are given in Supplementary
Fig. 8b.
Receptor expression using HRP and confocal microscopy. A total of 20,000
cells/well were seeded in 96-well plates and transfected with 100 to 150 ng receptor
vector. After 48 h of transfection, the cells were washed with PBS and ﬁxed with
4% PFA. After ﬁxation, the cells were washed, blocked with 1% BSA in PBS, and
incubated with antibodies against the N-terminal VSV-G epitope (for HRP
detection: clone P5D4, V5507, Sigma; 1:250 ﬁnal dilution in blocking buffer; for
confocal microscopy: Dylight™ 488 conjugated antibody, 600-441-386, Rockland,
1:500 ﬁnal dilution in blocking buffer). For the HRP-based detection, cells were
washed and developed using a polymer detection system (Ultravision, Empire
Genomics). A mixture was prepared by adding 30 μl of DAB in 1 ml of DAB
substrate (Sigma) to the cells after two additional washes. The reaction was
stopped by adding water. Optical density at 450 nm was measured in the plate
reader after one wash and addition of 30 μl of fresh water. For confocal micro-
scopy, cells were washed and covered with mounting medium. Pictures of indi-
vidual cells were recorded on an inverted confocal microscope (LSM 700, Zeiss,
×63 objective, excitation and emission wavelengths were 488 and 500–700 nm,
respectively.). Unlike confocal microscopy, the plate reader-based HRP mea-
surements do not report on receptor membrane localization, as labeling of
intracellular epitopes cannot be excluded even under non-permeabilizing
conditions.
Data analysis and statistics. In transcriptional reporter assays (Fig. 2b, c, Fig. 3,
Fig. 4b, Supplementary Table 7), FF RLU were divided by RE RLU yielding
[FF RLU / RE RLU], and thereby correcting for variability in cell number and
transfection efﬁciency58. For all samples on a given 96-well plate, [FF RLU / RE
RLU] ratios were normalized by those of uninduced control wells that
contained the same reporter on the same plate (yielding [FF RLU / RE RLU]
norm.), thereby allowing comparison of values collected in independent experi-
ments. For each reporter vector, three to ﬁve independent experiments were per-
formed for each receptor each in duplicate wells with mean values given.
Thresholds for induced or reduced receptor levels of 2.50- and 0.66-fold, respec-
tively, were deﬁned using the data of Fig. 2b that show below/above threshold
responses for reference GPCRs. Transcriptional reporters were analyzed separately
with no cross-reporter comparison or normalization. For instance, in Fig. 3 a linear
color scale was applied to each assay separately, as maximal levels of reporter
induction also reﬂect reporter sensitivity and not necessarily the relative strength of
pathway activation.
In antibody staining (Supplementary Fig. 3), the mean optical density was
determined at ﬁve positions in each well. Mean optical density values were
normalized by the mean optical density of rhodopsin transfected cells. For each
receptor, three independent experiments were performed.
For cAMP mobilization, ﬁve independent experiments were performed in
triplicate wells. Baseline and responses were deﬁned as described above and means
are given in Supplementary Fig. 4a and b.
For Ca2+ mobilization, three to ﬁve independent experiments were performed.
In each experiment, 15 single cells were analyzed. Baseline and responses
were deﬁned as described above and means are given in Supplementary
Fig. 5a and b.
For Opto-GPR33-mCh(-ΔCt) internalization, cells from at least ten images per
condition and experiment were analyzed as described above. Experiments were
performed in duplicate or triplicate dishes and means are given in Supplementary
Fig. 8a.
For Opto-GPR33-BT(-ΔCt) internalization, cells from at least 20 images per
condition were analyzed as described above. Experiments were performed in
triplicate wells and means are given in Supplementary Fig. 8b.
Data availability. Data supporting the ﬁndings of this manuscript are available
from the corresponding author upon reasonable request. All vectors and genes
created in this study are available through Addgene.org.
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